Abstract
Mutation of the human immunodeficiency virus by host cells inhibits viral dissemination by creating nonfunctional variants. However, viral mutation does not always eliminate the ability of the virus to disseminate and, in fact, is thought to promote persistence by generating functional mutants that evade immunity or drugs. How and where HIV mutates is not known. Accordingly, where and to what extent variants emerge may be determined by the cell type with optimal mutation apparatus as well as by the properties of the viral genomic sequence itself. Here we considered that HIV, which can infect B cells, may co-opt the Ig somatic hypermutation machinery to generate functional variants and asked whether the HIV envelope coding sequence can diversify in B cells. We show that an HIV envelope coding sequence transfected into B cells mutates in a manner consistent with somatic hypermutation, causing the production of viral protein variants. This result demonstrates that B cells can express and diversify HIV proteins. Thus, B cells may contribute to viral evasion and to the development of multi-drug resistance.
Keywords: B cells, HIV, quasi-species
Current HIV Research
Title: HIV Genes Diversify in B Cells
Volume: 6 Issue: 1
Author(s): Marilia Cascalho, Samuel J. Balin, Ted M. Ross and Jeffrey L. Platt
Affiliation:
Keywords: B cells, HIV, quasi-species
Abstract: Mutation of the human immunodeficiency virus by host cells inhibits viral dissemination by creating nonfunctional variants. However, viral mutation does not always eliminate the ability of the virus to disseminate and, in fact, is thought to promote persistence by generating functional mutants that evade immunity or drugs. How and where HIV mutates is not known. Accordingly, where and to what extent variants emerge may be determined by the cell type with optimal mutation apparatus as well as by the properties of the viral genomic sequence itself. Here we considered that HIV, which can infect B cells, may co-opt the Ig somatic hypermutation machinery to generate functional variants and asked whether the HIV envelope coding sequence can diversify in B cells. We show that an HIV envelope coding sequence transfected into B cells mutates in a manner consistent with somatic hypermutation, causing the production of viral protein variants. This result demonstrates that B cells can express and diversify HIV proteins. Thus, B cells may contribute to viral evasion and to the development of multi-drug resistance.
Export Options
About this article
Cite this article as:
Cascalho Marilia, Balin J. Samuel, Ross M. Ted and Platt L. Jeffrey, HIV Genes Diversify in B Cells, Current HIV Research 2008; 6 (1) . https://dx.doi.org/10.2174/157016208783571919
DOI https://dx.doi.org/10.2174/157016208783571919 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimers Disease
Current Alzheimer Research Determination of Spatial and Temporal Distribution of Microglia by 230nm-High-Resolution, High-Throughput Automated Analysis Reveals Different Amyloid Plaque Populations in an APP/PS1 Mouse Model of Alzheimers Disease
Current Alzheimer Research Early β-Amyloid-induced Synaptic Dysfunction Is Counteracted by Estrogen in Organotypic Hippocampal Cultures
Current Alzheimer Research Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer’s Disease? Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Development of Novel Amyloid Imaging Agents Based Upon Thioflavin S
Current Alzheimer Research Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations
Current Cardiology Reviews Desmopressin 30 Years in Clinical Use: A Safety Review
Current Drug Safety α7 Nicotinic Acetylcholine Receptors in Alzheimer’s Disease: Neuroprotective, Neurotrophic or Both?
Current Drug Targets Preparation and Characterization of Rivastigmine Loaded Human Serum Albumin (HSA) Nanoparticles
Current Drug Delivery A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Current Alzheimer Research Lead Finding for Acetyl Cholinesterase Inhibitors from Natural Origin: Structure Activity Relationship and Scope
Mini-Reviews in Medicinal Chemistry Using Non-Pharmacological Approaches for CJD Patient and Family Support as Provided by the CJD Foundation and CJD Insight
CNS & Neurological Disorders - Drug Targets The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease
Current Alzheimer Research The Contribution of Proteinase-Activated Receptors to Intracellular Signaling, Transcellular Transport and Autophagy in Alzheimer´s Disease
Current Alzheimer Research Repurposed Drugs in Metabolic Disorders
Current Topics in Medicinal Chemistry Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
Current Drug Targets Depression, Serotonin and Tryptophan
Current Pharmaceutical Design Cerebrovascular Pathology and Responsiveness to Treatment in Alzheimer’s Disease: A Systematic Review
Current Alzheimer Research